ADL
CDMO

Asset Dedication LLC’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Asset Dedication LLC’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-40
Closed – – 769
2018
Q1 		$0 Buy
+40
New +$124 ﹤0.01% 560

Other funds holding CDMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BP
Bandera Partners New York $221M AUM 10.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SIC
Schwartz Investment Counsel Plymouth, Michigan $3.01B AUM 27.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Asset Dedication LLC's CDMO Position: Q2 2018 in Review

Asset Dedication LLC sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q2 2018, closing a stake of 40 shares.

Asset Dedication LLC first reported a position in CDMO in Q1 2018 and held it in 1 quarter. The position peaked at $0 in Q1 2018. 81 funds tracked by Wall St. Rank hold CDMO as of Q2 2018.

  • Asset Dedication LLC reported no remaining Avid Bioservices, Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
  • Asset Dedication LLC sold 40 Avid Bioservices, Inc. Common Stock shares in Q2 2018.
  • Asset Dedication LLC first reported a position in Avid Bioservices, Inc. Common Stock in Q1 2018 and held it in 1 quarter.
  • Asset Dedication LLC's Avid Bioservices, Inc. Common Stock position peaked at $0 in Q1 2018.
  • 81 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q2 2018.

Based on Asset Dedication LLC's 13F filing for Q2 2018, filed 13 Aug 2018.